Reimbursement Challenges and Solutions with Molecular Biomarker Testing

Geoffrey R. Oxnard, MD; Lauren L. Ritterhouse, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Drs. Geoffrey Oxnard and Lauren Ritterhouse consider the current landscape of reimbursement for molecular biomarker testing, the need to run FDA-approved tests, and the role of CMS and local Medicare providers in testing reimbursement.

November 24, 2014

Is Research Translating to Meaningful Treatment to Patients?

Dr. Palmer describes how the direct relationship between treatment directed to change in the DNA actually affects the outcome of patients.

August 15, 2013

Personalizing Therapy for Patients With CML

Dr. Mauro addresses the debate over selecting first line therapy with three approved agents available.